24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
40.94% |
|
ALZHEIMERS |
28.65% |
|
PEPTIDOMIMETIC CD40L BINDING |
28.07% |
|
EBOLA |
2.34% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
56.15% |
|
ENZYME DYNAMICS |
25.24% |
|
PEPTIDOMIMETIC CD40L BINDING |
14.72% |
|
CANCER |
2.59% |
|
EBOLA |
.65% |
|
ATWRI1 MUTANT SCREENING |
.65% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
36.68% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
23.05% |
|
ENZYME DYNAMICS |
18.83% |
|
CANCER |
5.43% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
3.79% |
|
INFLUENZA |
2.81% |
|
ATSTP10 SUCROSE TRANSPORT |
2.39% |
|
RCA STABILITY SIMULATIONS |
2.05% |
|
ATSTP10 TRANSPORT SIMULATION |
1.98% |
|
PEPTIDOMIMETIC CD40L BINDING |
1.57% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.83% |
|
MEMBRANE TRANSPORT |
.34% |
|
NIPAH VIRUS DECOY PROTEINS |
.12% |
|
ATWRI1 MUTANT SCREENING |
.07% |
|
EBOLA |
.07% |